Phase II Study of Imatinib Mesylate (Gleevec, STI-571) (NSC#716051) and Decitabine (5-AZA-2'-Deoxycitidine) (NSC#127716), in Chronic Myelogenous Leukemia in Accelerated and Blastic Phases
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2013
At a glance
- Drugs Decitabine (Primary) ; Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 28 Aug 2007 Status changed from in progress to completed.
- 13 Sep 2005 New trial record.